GPC Biotech’s mission was to discover and develop novel anti-cancer drugs. The founding team raised two private financing rounds in 1997 and 1999, acquired a Boston-based drug discovery company, took GPC public in 2000 and listed GPC on Nasdaq in 2004. It developed an anti-cancer drug through clinical phase 3 and filed for market registration. In 2009, GPC Biotech merged with the US-based company Agennix Inc.
Company Details
- Employees
- 33
- Founded
- -
- Address
- Martinsried, De
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.gpc-biotech.com
- HQ
- Martinsried
Gpc Biotech Ag Questions
Gpc Biotech Ag's website is https://www.gpc-biotech.com
Gpc Biotech Ag's LinkedIn profile is https://de.linkedin.com/company/gpc-biotech
Gpc Biotech Ag has
33 employees.
View email and phone details for 33
employees at Gpc Biotech Ag.
Gpc Biotech Ag's industry is
Biotechnology Research
Gpc Biotech Ag's top competitors are
Morphosys,
Eleszto Genetika,
Iris Biotech Gmbh,
Sirion Biotech Gmbh (Revvity Gene Delivery),
Inpharma,
Amsilk Gmbh | Biogenius Materials,
Genome Protection, Inc,
Gpc Bio Usa,
Formycon Ag,
Biontech Se.
Gpc Biotech Ag's categories are Biotechnology Research
Gpc Biotech Ag's founding year is 1997
